
Axsome Therapeutics, Inc.
AXSMNASDAQHealthcare● Active
$235.14
+$2.82(+1.21%)
Market Cap$12.1B
P/E Ratio—
52W High$242.41
52W Low$96.09
Axsome Therapeutics, Inc.(AXSM)· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · AXSM · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.18B) | ($0.29B) | ($0.24B) | ($0.19B) | ($0.13B) |
| Depreciation & Amort. | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.09B | $0.00B | $0.06B | $0.04B | $0.02B |
| Change in Working Capital | ($0.02B) | $0.03B | ($0.03B) | $0.02B | $0.00B |
| Net Cash from Operations | ($0.09B) | ($0.13B) | ($0.15B) | ($0.12B) | ($0.11B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.00B) | ($0.00B) | ($0.00B) | ($0.05B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.01B) | ($0.00B) | $0.09B | $0.04B | $0.00B |
| Net Cash from Financing | $0.10B | $0.06B | $0.33B | $0.28B | $0.01B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.09B) | ($0.13B) | ($0.15B) | ($0.12B) | ($0.11B) |
| FCF Margin %(computed) | -14.70% | -33.36% | -53.83% | -234.25% | — |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · B
深入了解Axsome Therapeutics, Inc.
关于Axsome Therapeutics, Inc.(AXSM)现金流量表
Axsome Therapeutics, Inc. 2025财年经营活动现金流($0.09B),自由现金流($0.09B)(FCF利润率-14.70%),资本支出($0.00B)。
常见问题
AXSM · 4 问Axsome Therapeutics, Inc. 2025财年自由现金流($0.09B),同比up27.0%。
AXSM free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10